Plasmodium falciparum has evolved resistance to virtually every antimalarial introduced for widespread use, posing a major challenge to malaria control and elimination. Resistance emerged first ...

Malaria remains a major global health challenge, driven by the emergence and spread of resistance to frontline therapies. The dynamics of antimalarial drug resistance are shaped by parasite biology, ...

Malaria represents one of the most serious threats to human health worldwide, and preventing and curing this parasitic disease still depends predominantly on the administration of a small number of ...

Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission. The first-in-class clinical ...

Children with acute malnutrition across Africa and Asia have a higher risk of treatment failure and malaria reinfection, even after being given the best currently available and recommended malaria ...

The Calibr-Skaggs Institute for Innovative Medicines at Scripps Research and Kainomyx, Inc., today announced a new research collaboration to accelerate the discovery and development of next-generation ...

Malaria is a constant threat for nearly half of the world’s population, and people who travel to those areas are also at risk. Although the short-term side effects of prophylactic drugs are ...

Researchers at University of California San Diego analyzed the genomes of hundreds of malaria parasites to determine which genetic variants are most likely to confer drug resistance. The findings, ...

Artificial intelligence has exploded in popularity and is being harnessed by some scientists to predict which molecules could treat illnesses, or to quickly screen existing medicines for new ...

KYOTO, Japan — The antimalarial drug mefloquine may prove to be an effective treatment for progressive multifocal leukoencephalopathy (PML) in patients not infected with HIV, a small, preliminary ...

Polycystic ovary syndrome (PCOS) is an endocrine disorder that affects millions of people worldwide, including about 8–13% of reproductive-aged women, according to the World Health Organization.